Shaohua Lu, MD. PhD

Visiting Research Scholar

Shaohua Lu, MD. PhD

Visiting Research Scholar

Start Year


End Year



  • Fudan University Research Scholarship

Current Employment

  • Assistant Professor, Fudan University, China


  • Bains S, Eguchi T, Warth A, Yeh YC, Nitadori JI, Woo KM, Chou TY, Dienemann H, Muley T, Nakajima J, Shinozaki-Ushiku A, Wu YC, Lu S, Kadota K, Jones DR, Travis WD, Tan KS, Adusumilli PS. Procedure-specific risk prediction for recurrence in patients undergoing lobectomy or sublobar resection for small (</=2 cm) lung adenocarcinoma: an international cohort analysis. J Thorac Oncol. 2019;14(1):72-86.
  • Eguchi T, Kameda K, Lu S, Bott MJ, Tan KS, Montecalvo J, Chang JC, Rekhtman N, Jones DR, Travis WD, Adusumilli PS. Lobectomy is associated with better outcomes than sublobar resection in spread through air spaces (STAS)-positive T1 lung Adenocarcinoma: a propensity score-matched analysis. J Thorac Oncol. 2019;14(1):87-98.
  • Kameda K, Eguchi T, Lu S, Qu Y, TanKS, Kadota K, Adusumilli PS, Travis WD. Implications of the eighth edition of the TNM proposal: invasive vs. total tumor size for the T descriptor in pathologic stage I-IIA lung adenocarcinoma. J Thorac Oncol. 2018;13(12):1919-1929.
  • Takahashi Y, Eguchi T, Kameda K, Lu S, Vaghjiani RG, Tan KS, Travis WD, Jones DR, Adusumilli PS. Histologic subtyping in pathologic stage I-IIA lung adenocarcinoma provides risk-based stratification for surveillance. Oncotarget. 2018;9(87):35742-35751.
  • Takahashi Y, Eguchi T, Lu S, Downey RJ, Jones DR, Travis WD, Adusumilli PS. Preponderance of high-grade histologic subtype in autologous metastases in lung adenocarcinoma. Am J Respir Crit Care Med. 2018;155(3):1203-1204. 
  • Lu S, Tan KS, Kadota K, Eguchi T, Bains S, Rekhtman N, Adusumilli PS, Travis WD. Spread through air spaces (STAS) is an independent predictor of recurrence and lung cancer specific death in squamous cell carcinoma. J Thorac Oncol. 2017;12(2):223-234. 
  • Aliyev N, Takahashi Y, Lu S, Mayor M, Adusumilli PS. Intraoperative subtyping of lung adenocarcinoma: an unmet need. Transl Cancer Res. 2016;5:S40-S3.